Analytical Data
-
Gene name
HDDC2
- Application
-
Alternative Names
HDDC2;C6orf74;NS5ATP2;5'-deoxynucleotidase HDDC2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7Z4H3
-
Expression Region
1-204aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMASVSSA TFSGHGARSL LQFLRLVGQL KRVPRTGWVY RNVQRPESVS DHMYRMAVMA MVIKDDRLNK DRCVRLALVH DMAECIVGDI APADNIPKEE KHRREEEAMK QITQLLPEDL RKELYELWEE YETQSSAEAK FVKQLDQCEM ILQASEYEDL EHKPGRLQDF YDSTAGKFNH PEIVQLVSEL EAERSTNIAA AASEPHS
-
Molecular Weight
26 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HDDC2, or HLA-DQ associated domain containing 2, is a protein that has garnered attention due to its potential roles in immune regulation and autoimmunity. As a member of the HDDC family, HDDC2 is believed to be involved in various biological processes, including antigen presentation and modulation of immune responses. Research indicates that alterations in HDDC2 expression may be linked to autoimmune diseases, making it a candidate for therapeutic intervention and biomarker discovery. Furthermore, studies have suggested that HDDC2 interacts with other immune-related molecules, supporting its involvement in complex signaling pathways that govern immune system functions. Understanding the structure and function of HDDC2 is crucial for elucidating its role in health and disease, and ongoing research aims to explore its potential implications in immunotherapy and the management of autoimmune conditions. The investigation of HDDC2 could pave the way for novel therapeutic strategies aimed at modulating immune responses and improving outcomes for individuals with autoimmune disorders.
